The global market for cancer-focused genetic testing services is set for a period of exceptional growth, with projections estimating a market size of USD 8,472.70 million by 2024. The market is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2034, ultimately reaching a significant valuation of USD 19.3 …